This Coca-Cola Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

BenzingaJan 7 22:10

Ascendis Pharma Initiated at Buy by UBS

Dow JonesJan 7 20:56 · Ratings

Ascendis Pharma Analyst Ratings

BenzingaJan 7 20:44 · Ratings

UBS Initiates Ascendis Pharma A/S(ASND.US) With Buy Rating, Announces Target Price $196

Futu NewsJan 7 19:31 · Ratings

BofA Securities Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $203

Futu NewsJan 7 08:32 · Ratings

Ascendis Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireJan 6 21:30